Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

DU PONT MERCK DRUG GETS GO-AHEAD

Jan. 9, 1991

H AND Q CONFERENCE BRIEFS

Jan. 9, 1991

NEWS BRIEFS

Jan. 9, 1991

APPOINTMENTS AND ADVANCEMENTS

Jan. 9, 1991

HAMBRECHT AND QUIST CONFERENCE BRIEFS:

Jan. 8, 1991

NEWS BRIEFS

Jan. 8, 1991

ADVANCEMENTS AND APPOINTMENTS

Jan. 8, 1991

REPLIGEN LICENSES ANTI-INFLAMMATORY MAb

Jan. 8, 1991

GENENTECH SIGNS $15M PACT WITH GLYCOMED

Jan. 8, 1991

AMGEN EXPECTS NEUPOGEN TO GET NOD

Jan. 8, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...